Literature DB >> 19651786

Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies.

Zoltán Nemes1, Goran Petrovski, Maarten Aerts, Kjell Sergeant, Bart Devreese, László Fésüs.   

Abstract

The alpha-synuclein immunopositive and chaotrope-insoluble material from human brains with Lewy body pathology was analyzed by mass spectrometry. From the proteinase K-cleavable peripheral fraction of Lewy bodies, which was densely cross-linked by gamma-glutamyl-epsilon-lysine bonds between HspB1 and ubiquitin in a pattern similar to neurofibrillary tangles (Nemes, Z., Devreese, B., Steinert, P. M., Van Beeumen, J., and Fésüs, L. (2004) FASEB J. 18, 1135-1137), 53 proteins were identified. In the core of Lewy bodies only alpha-synuclein was found, and it contained a low amount of intramolecular cross-links between Gln-99 and Lys-58. In vitro cross-linking of alpha-synuclein by transglutaminases 1-3 and 5 produced a heterogeneous population of variably cross-linked alpha-synucleins in solution, which inhibited the aggregation of the protein into amyloid. However, in the presence of phosphatidylserine-rich membranes and micromolar calcium concentrations, the cross-linking by transglutaminases 1, 2, and 5 showed specificity toward the utilization of Gln-99 and Lys-58. As shown by thioflavin T fluorescence monitoring, the formation of this cross-link accelerated the aggregation of native alpha-synuclein. Chemical cross-linking of residues 58-99 triggered amyloid formation, whereas such bonding of residues 99 to 10 was inhibitory. Our findings reveal the pivotal role of membrane attachment and transglutaminase-mediated intermolecular cross-linking for the propagative misfolding and aggregation of alpha-synuclein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651786      PMCID: PMC2785653          DOI: 10.1074/jbc.M109.033969

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  The structural basis for the regulation of tissue transglutaminase by calcium ions.

Authors:  R Casadio; E Polverini; P Mariani; F Spinozzi; F Carsughi; A Fontana; P Polverino de Laureto; G Matteucci; C M Bergamini
Journal:  Eur J Biochem       Date:  1999-06

2.  Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.

Authors:  Takashi Konno; Takashi Morii; Akiyoshi Hirata; Shin-ichi Sato; Shigetoshi Oiki; Koji Ikura
Journal:  Biochemistry       Date:  2005-02-15       Impact factor: 3.162

Review 3.  Tools for the detection and quantitation of protein transglutamination.

Authors:  Zoltan Nemes; Goran Petrovski; László Fésüs
Journal:  Anal Biochem       Date:  2005-07-01       Impact factor: 3.365

Review 4.  The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.

Authors:  Makoto Hashimoto; Kohichi Kawahara; Pazit Bar-On; Edward Rockenstein; Leslie Crews; Eliezer Masliah
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Involucrin cross-linking by transglutaminase 1. Binding to membranes directs residue specificity.

Authors:  Z Nemes; L N Marekov; P M Steinert
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

6.  Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease.

Authors:  S Y Kim; P Grant; J H Lee; H C Pant; P M Steinert
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

7.  Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein.

Authors:  Qin Wang; Randall L Woltjer; P J Cimino; Catherine Pan; Kathleen S Montine; Jing Zhang; Thomas J Montine
Journal:  FASEB J       Date:  2005-03-03       Impact factor: 5.191

8.  Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease.

Authors:  Adrien W Schmid; Diego Chiappe; Vérène Pignat; Valerie Grimminger; Ivan Hang; Marc Moniatte; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing.

Authors:  E Candi; G Melino; A Lahm; R Ceci; A Rossi; I G Kim; B Ciani; P M Steinert
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

View more
  12 in total

Review 1.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation.

Authors:  Raymond Kwan; Shinichiro Hanada; Masaru Harada; Pavel Strnad; Daniel H Li; M Bishr Omary
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

Review 4.  Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.

Authors:  Manuela Basso; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

5.  Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.

Authors:  Norihisa Nishimichi; Hiromi Hayashita-Kinoh; Chun Chen; Haruo Matsuda; Dean Sheppard; Yasuyuki Yokosaki
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

6.  Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.

Authors:  Adrien W Schmid; Enrico Condemi; Gabriele Tuchscherer; Diego Chiappe; Manfred Mutter; Horst Vogel; Marc Moniatte; Yury O Tsybin
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

7.  Naturally Occurring Epsilon Gamma Glutamyl Lysine Isopeptide Crosslinks in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Oksana Lockridge; Lawrence M Schopfer
Journal:  ACS Omega       Date:  2022-06-16

8.  Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Authors:  Chen Liu; Wei Wang; Nicholas Parchim; Roxanna A Irani; Sean C Blackwell; Baha Sibai; Jianping Jin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

9.  Transglutaminase 2 exacerbates α-synuclein toxicity in mice and yeast.

Authors:  Hilary Grosso; Jong-Min Woo; Kang-Woo Lee; Joo-Young Im; Eliezer Masliah; Eunsung Junn; M Maral Mouradian
Journal:  FASEB J       Date:  2014-06-26       Impact factor: 5.191

Review 10.  Vertebrate food products as a potential source of prion-like α-synuclein.

Authors:  Bryan Andrew Killinger; Viviane Labrie
Journal:  NPJ Parkinsons Dis       Date:  2017-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.